Financial report preview | Oracle Corporation (ORCL.US) Q2 performance announcement imminent, can "AI + Cloud" continue its glory?
Oracle (ORCL.US) will release its second quarter financial report.
Oracle Corporation (ORCL.US) will announce its second quarter financial report after the US stock market closes on December 9th (Monday). Analysts are closely monitoring the growth of cloud service revenue for this technology giant.
Analysts expect Oracle Corporation to have Q2 revenue of $14.13 billion, a 9% year-on-year increase; net profit of $3.05 billion, and earnings per share of $1.07. In comparison, the company had a net profit of $2.5 billion and earnings per share of $0.89 in the same period last year. The company's largest business, cloud services, is expected to achieve revenue of $5.98 billion, a 25% increase from the same period last year.
Oracle Corporation's stock price rose 2.93% last Friday to $191.69. Driven by the trend of artificial intelligence (AI), the company's stock price has surged over 80% so far this year, reaching a historic high. In the previous quarter, Oracle Corporation's performance exceeded analysts' expectations, with the company stating that there was a significant increase in demand for cloud-based training of large AI language models.
Overall, Wall Street analysts have given Oracle Corporation a "moderate buy" rating with an average target price of $181.93, which is 5% lower than the current level.
Related Articles

US Stock Market Move | AI application software stocks rise, Applovin (APP.US) up more than 6%

US Stock Market Move | Orforglipron's oral weight-loss drug program achieves success in Phase III trial, causing Eli Lilly (LLY.US) stock to rise more than 3%.

US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rose more than 3%. Morgan Stanley predicts that the company's gross profit margin will surpass 60% in the fourth quarter.
US Stock Market Move | AI application software stocks rise, Applovin (APP.US) up more than 6%

US Stock Market Move | Orforglipron's oral weight-loss drug program achieves success in Phase III trial, causing Eli Lilly (LLY.US) stock to rise more than 3%.

US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rose more than 3%. Morgan Stanley predicts that the company's gross profit margin will surpass 60% in the fourth quarter.






